Chiome Bioscience Inc.
Chiome Bioscience Inc. (JPX: 4583) is trading at ¥108.00, about ₹66 at today's JPY/INR rate, as of 30 Sep 2026, 2:30 AM ET, down 0.92% today. Indian residents can buy Chiome Bioscience from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
¥103.00
Today's high
¥110.00
52 week low
¥65.00
52 week high
¥142.00
4583 opened at ¥107.00, closed previously at ¥109.00, and has traded between ¥65.00 and ¥142.00 over the past 52 weeks.
About
Chiome Bioscience Inc. engages in the research and development of drug discovery technology platforms worldwide. It operates in two segments, Drug Discovery Business and Drug Discovery Support Business. The company offers ADLib System, a technology for generating monoclonal antibodies which is used to generate antibodies for drug discovery research; and Human ADLib System, which converts chicken antibody genes to humanized antibodies. It also provides protein expression and purification services; stable cell line development services for recombinant protein and antibody production; and antibody generation services using the ADLib system. In addition, the company's product pipeline under Phase 1 trial comprises ADCT-701, an anti-dlk1 antibody for treating liver cancer; CBA-1205, an afucosylated anti-dlk1 antibody for liver cancer, lung cancer, and neuroblastoma; and CBA-1535, an anti 5T4/WAIF1 antibody for malignant mesothelioma, small cell lung cancer, non-small cell lung cancer, and triple negative breast cancer (TNBC). Further, its product pipeline under preclinical study includes PCDC, an anti- CDCP1 antibody for lung, colorectal, pancreatic, breast, and ovarian tumors; PTRY, an antibody 5T4/CD3/PD-L1 for treating malignant mesothelioma, small cell lung cancer, non-small cell lung cancer, and TNBC; BMAA, an anti-semphorin3a antibody for treating renal and other diseases; LIV-2008/2008b, an anti-TROP-2 antibody for the treatment of TNBC, lung cancer, and colorectal cancer; PFKR, an anti-CX3CR1 antibody for secondary progressive multiple sclerosis; and PXLR, an anti-CXCL1/2/3/5 antibody for the treatment of gastric, breast, and ovarian tumors. Chiome Bioscience Inc. was incorporated in 2005 and is headquartered in Tokyo, Japan.
Key statistics
Avg. volume
1.28M
Market cap
¥7.84B
P/E Ratio
-8.24
Price-to-sales ratio
12.75
Enterprise value
¥6.32B
Free cash flow yield
-13.43%
Debt-to-equity ratio
0.04
Return on equity
-87.59%
ROIC
-68.07%
Beta
1.86
Dividend yield
0.00%
Last dividend
¥0.00
Financial overview
Revenue
¥593.29M
Earnings per share
-¥14.47
Free cash flow
-¥976.07M
Net profit margin
-150.49%
Gross margin
61.00%
EBITDA
-¥972.64M
Revenue growth
-24.02%
Similar securities
This is not an investment recommendation
How to buy Chiome Bioscience from India
Indian residents can buy Chiome Bioscience shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to JPY.
Search for Chiome Bioscience and place an order
Find Chiome Bioscience by name or by its ticker, 4583, and choose an order type. The Tokyo Stock Exchange typically trades in units of 100 shares. Chiome Bioscience trades 5:30 am – 12:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Chiome Bioscience position in JPY and INR. Chiome Bioscience pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Chiome Bioscience from India
Trading and taxes when buying Chiome Bioscience from India
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm JST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneChiome Bioscience does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- Estate or inheritance tax
- May applyJapan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Chiome Bioscience stock?
Yes. Chiome Bioscience (4583) has been listed on the Tokyo Stock Exchange since 2011, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to JPY. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Chiome Bioscience share cost in rupees?
One Chiome Bioscience share is ¥108.00 — about ₹66 at a JPY/INR rate of 0.6103 on 29 Sep 2026. Both the Chiome Bioscience price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Chiome Bioscience from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Chiome Bioscience?
The Tokyo Stock Exchange typically trades in units of 100 shares.
How are gains on Chiome Bioscience shares taxed in India?
Japan generally does not levy capital gains tax on non-resident individual investors, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the JPY/INR rate on the purchase and the sale date, so the rupee move counts alongside the Chiome Bioscience price. Paasa issues a capital-gains statement for your return.
Does Chiome Bioscience pay a dividend?
No. Chiome Bioscience does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Chiome Bioscience from India?
The Tokyo Stock Exchange trades 5:30 am – 12:00 pm IST in Indian time. It also halts for lunch, 8:00 am – 9:00 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on Chiome Bioscience shares held from India?
Japan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir. It applies to your overall holdings in that jurisdiction rather than to any one position.
Do I have to declare Chiome Bioscience shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Chiome Bioscience holding, its cost and its closing value.
How do I sell Chiome Bioscience and bring the money back to India?
You sell during market hours (5:30 am – 12:00 pm IST) and the proceeds settle in JPY in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.